News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
258,860 Results
Type
Article (13826)
Company Profile (293)
Press Release (244741)
Section
Business (79302)
Career Advice (148)
Deals (13178)
Drug Delivery (31)
Drug Development (50260)
Employer Resources (31)
FDA (5669)
Job Trends (5112)
News (144025)
Policy (10014)
Tag
Academia (901)
Alliances (21438)
Alzheimer's disease (729)
Approvals (5632)
Artificial intelligence (58)
Bankruptcy (97)
Best Places to Work (4459)
Biotechnology (241)
Breast cancer (54)
Cancer (564)
Cardiovascular disease (51)
Career advice (129)
CAR-T (43)
Cell therapy (146)
Clinical research (39569)
Collaboration (201)
Compensation (83)
COVID-19 (998)
C-suite (50)
Cystic fibrosis (61)
Data (606)
Diabetes (62)
Diagnostics (1190)
Earnings (28560)
Events (46457)
Executive appointments (149)
FDA (5910)
Funding (205)
Gene editing (47)
Gene therapy (126)
GLP-1 (288)
Government (1062)
Healthcare (6524)
Infectious disease (1027)
Inflammatory bowel disease (89)
IPO (7166)
Job creations (859)
Job search strategy (125)
Layoffs (181)
Legal (1372)
Lung cancer (100)
Manufacturing (65)
Medical device (2549)
Medtech (2550)
Mergers & acquisitions (6087)
Metabolic disorders (199)
Neuroscience (907)
NextGen Class of 2024 (1994)
Non-profit (841)
Northern California (777)
Obesity (116)
Opinion (90)
Parkinson's disease (55)
Patents (45)
People (24881)
Pharmaceutical (48)
Phase I (13905)
Phase II (18396)
Phase III (11679)
Pipeline (136)
Postmarket research (846)
Preclinical (5867)
Radiopharmaceuticals (203)
Rare diseases (138)
Real estate (1409)
Regulatory (8157)
Research institute (931)
Southern California (715)
Startups (1963)
United States (6500)
Vaccines (152)
Weight loss (71)
Date
Today (95)
Last 7 days (473)
Last 30 days (1714)
Last 365 days (20697)
2024 (17573)
2023 (22412)
2022 (26824)
2021 (27808)
2020 (23361)
2019 (16228)
2018 (11739)
2017 (13746)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7615)
2010 (7429)
Location
Africa (146)
Asia (16761)
Australia (2819)
California (1756)
Canada (638)
China (134)
Colorado (64)
Connecticut (69)
Europe (36062)
Florida (189)
Georgia (50)
Illinois (109)
Indiana (51)
Kansas (54)
Maryland (256)
Massachusetts (1446)
Michigan (45)
Minnesota (81)
New Jersey (478)
New York (535)
North Carolina (378)
Northern California (777)
Ohio (71)
Pennsylvania (371)
South America (207)
Southern California (715)
Texas (178)
Washington State (196)
258,860 Results for "centauri therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Centauri Therapeutics Strengthens Senior Leadership Team With Three Key Appointments
Centauri Therapeutics Limited, an immunotherapy company focused on the treatment of infectious diseases, announced three senior appointments: Dr Jennifer Schneider as Chief Executive Officer, Dr Helen Bright as Vice President of Research & Development, and Professor David Roblin FRCP FMedSci as Chair of the Board of Directors.
July 12, 2022
·
4 min read
Policy
Galaxy Medical Receives CE Mark for CENTAURI Pulsed Electric Field System
Galaxy Medical announced that it received the CE Mark for its CENTAURI Pulsed Electric Field System and launched its commercial program.
August 29, 2022
·
3 min read
Centauri Therapeutics Closes £24 Million GBP Series A Investment Round
Centauri Therapeutics Limited, an immunotherapy company founded by Animatrix Founders LLP and focused on the treatment of infectious diseases, announced the close of its £24 million GBP Series A investment round.
February 16, 2022
·
3 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
NeuroEM Therapeutics(R) Accepted into StartUp Health’s Alzheimer’s Moonshot Community(TM)
September 19, 2024
·
4 min read
Deals
CardioFocus Acquires Electrophysiology Division of Galvanize Therapeutics
CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrythmias, announced the acquisition of Galvanize Therapeutics’ Electrophysiology Technology division.
January 11, 2024
·
2 min read
Layoffs
Spero Therapeutics to Lay Off 39% of Employees
Following disappointing results for an antibiotic candidate whose development program is now being suspended, Spero Therapeutics is looking to extend its cash runway while it focuses on other assets in its pipeline.
October 30, 2024
·
1 min read
·
Angela Gabriel
Deals
Centauri Therapeutics to Attend Scientific and Investor Conferences
Centauri Therapeutics, an immunotherapy company active in oncology and infectious diseases, announces that it will attend the following scientific and investor conferences
October 1, 2019
·
1 min read
Layoffs
Relay Therapeutics to Lay Off 10% of Workforce
Relay Therapeutics is cutting its workforce to help streamline its research organization as it looks to complete its first large-scale, pivotal clinical trial.
October 4, 2024
·
1 min read
·
Angela Gabriel
Business
Centauri response by Dr Mike Westby, CEO of Centauri Therapeutics, to Dr Rick Bright, BARDA, Forbes article 10 May 19, “Building New Models To Support The Ailing Antibiotics Market”
Centauri Therapeutics (“Centauri”) is an immunotherapy company active in oncology and infectious diseases.
May 23, 2019
·
3 min read
1 of 25,886
Next